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Abstract In the brain inwardly rectifying potassium channel
Kir7.1 subunits are predominantly expressed in the choroid
plexus and meninges. To investigate this tissue-specific expres-
sion pattern, we characterized the genomic organization and the
5P proximal promoter of the rat Kir7.1 gene (Kcnj13). Starting
from the major transcriptional initiation site, three exons in
Kcnj13 give rise to the dominant V1.45 kb transcript in brain.
Adjacent to the transcriptional start the minimal promoter which,
uncommon for ion channels, contains a TATA- and CAAT-box is
controlled by AP-1 factors and accounts for high gene expression
levels. Luciferase reporter gene responses driven by the first 2.1
kb of the 5P flanking region were similarly high in epithelial
FRTL-5 and neuronal N2A cells, suggesting that neuron-specific
repressor elements are located remote from the non-selective
minimal promoter. ß 2000 Federation of European Biochem-
ical Societies. Published by Elsevier Science B.V. All rights
reserved.
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1. Introduction
Since the cloning of the ¢rst gene encoding a subunit of
inwardly rectifying K (Kir) channels in 1993, a total of 15
di¡erent subunits with conserved primary amino acid sequen-
ces but di¡erent functional characteristics have been identi¢ed
in mammals [1]. Both in the developing and adult animal, they
are expressed in a variety of tissues and have been found to
control the resting potential, maintain K homeostasis, trans-
duce cellular metabolism into excitability and regulate cell
growth and di¡erentiation. The expression pattern of Kir
transcripts in the brain is highly di¡erential, with some mem-
bers being ubiquitously expressed but others restricted to ei-
ther neurons or glia, to brain structures segregated during
ontogeny, or to nuclei associated with functional systems
[2,3]. However, to date little is known about the molecular
mechanism that controls the cell-speci¢c expression of the
di¡erent Kir genes.
The Kir channel subunit Kir7.1, which was recently isolated
and mapped to chromosomal locus 2q37 in man (Kcnj13) [4],
represents the most unusual member of this family: its pri-
mary structure is only moderately homologous to other sub-
units, and its functional properties are unique [5^7]. In partic-
ular, due to the presence of a non-conserved residue in the
channel’s outer pore region, Kir7.1 does not follow some of
the salient features of ion permeation typical of classic Kir
channels [8], e.g. it exhibits an extremely small unitary con-
ductance of V50 fS, and this conductivity is virtually inde-
pendent of extracellular [K]. Of relevance in this research, in
situ hybridization [6] and immunocytochemistry [9] revealed
that in the brain Kir7.1 subunits are absent from neurons and
glia but are likely expressed at unusually high density (9 103
channels/Wm2 cell membrane) within epithelial cells of the
choroid plexus and meninges. Moreover, it was found
that, in contrast to other transporting epithelia of the thyroid
or intestine, Kir7.1 subunits are targeted to the apical side of
choroid plexus cells, possibly in conjunction with a Na/K-
ATPase [9]. So far no molecular signals that may be involved
in the polarized targeting in epithelia have been recognized in
Kir7.1. However, in other membrane proteins this segregation
is likely controlled by sorting motifs in the primary structure
of the COOH-terminus (basolateral) or transmembrane/extra-
cellular region [10,11]. In contrast, tissue speci¢city and the
level of expression are more likely determined by cis-acting
elements located within the 5P £anking regions of the gene
[12,13]. To address the issue of the highly speci¢c tissue
expression of Kir7.1, we determined the genomic structure
of the rat Kir7.1 (rKir7.1) gene, located the transcription ini-
tiation site and analyzed the promoter activity of the 5P £ank-
ing sequence using a luciferase reporter assay in various cell
lines.
2. Material and methods
2.1. Cell culture
Neuro2A neuroblastoma cells (N2A, No. CLL131, American Type
Culture Collection, Rockville, MD, USA) and HEK293 cells (No.
CRL1573) were maintained in Dulbecco’s modi¢ed Eagle’s medium,
supplemented with non-essential amino acids (N2A), 10 mM HEPES
(HEK293), 10% fetal bovine serum, 2 mM glutamine and 100 U/ml
penicillin/streptomycin (HEK293 and N2A), at 37‡C and 5% CO2.
FRTL-5 cells (No. 91030711; European Collection of Cell Cultures,
Salisbury, UK), a strain of rat thyroid follicular cells, were grown in
Coon’s modi¢ed Ham’s F12 medium supplemented with 5% fetal
bovine serum, 2 mM glutamine, 10 Wg/ml insulin, 10 nM hydrocorti-
sol, 10 Wg/ml transferrin, 10 ng/ml Gly-His-Lys acetate, 10 ng/ml so-
matostatin, 10 U/ml TSH and 100 U/ml penicillin/streptomycin at
37‡C and 5% CO2.
2.2. Protein extraction and Western blotting
For protein extraction N2A, HEK293 and FRTL-5 cells were
washed with phosphate bu¡ered saline (PBS) and harvested by scrap-
ing the cell layer and subsequent low speed centrifugation of the cell
suspension. Cell pellets and tissue preparations from Wistar rats were
homogenized in ice cold lysis bu¡er (50 mM Tris pH 7.4, 150 mM
NaCl, 5 mM EGTA, protease inhibitors [1 Wg/ml leupeptin and pep-
statin A, 2 Wg/ml aprotinin, 1 mM PMSF], 1% Triton X-100) and
cleared from the non-soluble components by high speed centrifugation
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for 5 min at 4‡C. Equal amounts of protein extracts (estimated using
the BioRad protein assay) were separated by polyacrylamide gel elec-
trophoresis and electroblotted onto Immobilon P membranes (Milli-
pore, Badford, MA, USA). Western blots were probed with polyclon-
al rabbit Kir7.1 antibodies (1:1500; kindly provided by R. Veh,
Berlin) and detected with horseradish peroxidase conjugated goat
anti-rabbit immunoglobulins (1:5000; Jackson ImmunoResearch Lab-
oratories, West Grove, PA, USA) using an enhanced chemilumines-
cence detection system (ECL; Amersham, Buckinghamshire, UK).
2.3. Genomic cloning
For analysis of the Kir7.1 gene structure, a rat genomic V-phage
library (DASH; Stratagene, La Jolla, CA, USA) was homology
screened using a 32P-labeled polymerase chain reaction (PCR) frag-
ment comprising bp 642^1262 (Fig. 1) of the 3P region of the rat
Kir7.1 cDNA. Screening of a total of 106 plaques under high strin-
gency conditions resulted in the isolation of six positive clones con-
taining inserts between 12 and 15 kb in length. V clones were plaque
puri¢ed, and the DNA was puri¢ed using the Qiagen Lambda Midi
Kit (Qiagen, Hilden, Germany) and sequenced from both sides with
the BigDye terminator Kit on an ABI Prism 310 Genetic Analyzer
(PE Applied Biosystems, Weiterstadt, Germany).
2.4. Reverse transcriptase and rapid ampli¢cation of cDNA ends
(RACE)-PCR
Reverse transcription (RT)-PCR was carried out with Superscript II
reverse transcriptase (Life Technologies, Gaithersburg, MD, USA)
and 30 cycles of PCR ampli¢cation using Taq polymerase (Qiagen).
5P RACE was performed according to the manufacturer’s instructions
(Life Technologies) with 350 ng poly(A)+ RNA from rat tissue
(and FRTL-5 cells) as the template and a Kir7.1-speci¢c primer
(5P-TTAGGTTTGCCATCTTTGTGAGC-3P) located 520 bp down-
stream of the translational start site. In subsequent PCR ampli¢ca-
tions, the ¢rst and nested primers were 5P-GTGAATCGGATTGA-
GAAAGC-3P and 5P-CTGGGGAACATGGTGCCATAGC-3P and
were located 500 and 360 bp, respectively, downstream of the trans-
lational start site. PCR products were puri¢ed from agarose gels by
QiaExII (Qiagen), and 60^90 ng of the DNA fragment were directly
sequenced. For 3P RACE, rat brain poly(A)+ RNA was reverse tran-
scribed using a 3P RACE adapter primer (Life Technologies). The
subsequent PCR ampli¢cation was performed using a Kir7.1-speci¢c
primer (5P-GCAAGAAGGCACTGGGGAAATC-3P) located 340 bp
upstream of the stop codon and an anchor primer homologous to the
3P RACE adapter tail.
2.5. Luciferase reporter gene assay
The 5P £anking sequences of the rKir7.1 gene were inserted into
pGL3-Basic (Promega, Madison, WI, USA) to generate promoter/¢re-
£y luciferase constructs. The SV40 promoter in pGL3 was used as
positive control. Promoter fragments of rKir7.1 were generated by
PCR from the phage clone DNA, and fragment deletion of the pa-
rental reporter plasmid. Proofreading polymerases pfu (Stratagene)
and pfx (Life Technologies) were used to minimize ampli¢cation er-
rors, and constructs were con¢rmed by sequencing and restriction
analysis. Plasmid DNA was puri¢ed by Qiagen anion exchange chro-
matography.
For analysis of reporter gene constructs, FRTL-5 cells were grown
to con£uency, washed with PBS, harvested using trypsin (0.1% in
PBS/0.02% EDTA) and resuspended in a solution containing 120
mM KCl, 0.15 mM CaCl2, 10 mM K2HPO4, 10 mM KH2PO4,
5 mM glutathione, 2 mM ATP, 2 mM EGTA, 5 mM MgCl2 and
25 mM HEPES (pH 7.6). A 400 Wl aliquot of cells (v 1U106 cells)
was electroporated (965 WF and 350 V) with 20 Wg of the ¢re£y lu-
ciferase reporter plasmid and 2 Wg of the Renilla luciferase plasmid
(pRL-TK or pRL-SV40; Promega) at a 10:1 ratio (Gene Pulser Sys-
tem, BioRad, Hercules, CA, USA) and subsequently replated. N2A
and HEK293 cells, plated on 30 mm dishes, were transfected with 1 Wg
of ¢re£y luciferase reporter plasmid and 0.1 Wg Renilla luciferase
plasmid. For manipulation of signaling pathways, 0.1 Wg of the vec-
tors carrying PKA and MAP/ERK kinase kinase (MEKK1; Strata-
gene) were cotransfected. Forty-eight h after transfection all cell lines
were washed with PBS, exposed to 500 Wl of 1U passive lysis bu¡er
(Promega) for 15 min. Cytosolic cell extracts were cleared of debris by
centrifugation. Twenty Wl of the supernatant was assayed for lucifer-
ase activity on a Berthold luminometer using the dual luciferase re-
porter assay system (Promega).
3. Results and discussion
3.1. Genomic structure of Kcnj13
Homology screening of a rat genomic V-phage library with
a Kcnj13 cDNA probe resulted in the identi¢cation of four
overlapping clones, 4B, 6A, 5A2 and 10A, that cover a total
of 24.6 kb of genomic DNA in length (Fig. 1A). Analysis of
this sequence and comparison with the rKir7.1 cDNA [9]
revealed that, typical of the multiple exon structure known
Fig. 1. Genomic structure of Kcnj13. A: Schematic representation illustrating that Kcnj13 is composed of three exons (black boxes) and two in-
trons £anked by conventional splice donor and acceptor sites. A total of 24.6 kb of genomic sequence have been deduced from the four over-
lapping genomic phage clones shown (4B, 6A, 5A2 and 10A). B: The positions of the transmembrane segments M1 and M2, and the pore re-
gion H5 are indicated in the rat brain Kir7.1 cDNA as determined from genomic and total RNA analysis. The ORF is shown as a shaded
box, and 5P and 3P UTRs are represented by black lines. The gene bank accession number for the Kcnj13 genomic sequence is AJ292748.
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in Kir channels (e.g. [14^20]), the Kir7.1 cDNA is likely en-
coded by three exons. First, the open reading frame (ORF) of
Kir7.1 is disrupted and split into two exons (exon 2 and 3) at
a glycine (position 154) in the COOH-terminal part of trans-
membrane segment M2 by an intron which is 2081 bp in
length and £anked by conserved splice 5P donor and 3P accep-
tor sites (Fig. 1). In exon 3, only 31 bp downstream of the
stop codon, a putative polyadenylation signal sequence (5P-
ATTAAATATA-3P) was identi¢ed. 3P RACE-PCR with
whole rat brain RNA revealed that in Kir7.1 transcripts the
poly(A) tail is indeed adjoined to the polyadenylation site at a
distance of 33 bp, yielding a total length of 698 bp for exon 3.
To determine the 5P structure of Kcnj13 and the exact tran-
scriptional initiation site we performed 5P RACE-PCR with
whole rat brain RNA. Using antisense primers derived from
the rKir7.1 ORF together with 5P RACE-speci¢c primers a
single PCR product was ampli¢ed, indicating one major tran-
scriptional start site for Kir7.1 mRNAs in the rat brain. Se-
quence analysis of the 5P UTR uncovered 133 bp upstream of
the start codon, in which the initial 117 bp are coded by exon
1 and the following 16 bp by exon 2 (476 bp). Further se-
quence analysis revealed that the intron separating both exons
is 4772 bp in length (Fig. 1A). Consequently, the Kir7.1
cDNA in rat brain analyzed here comprises 1291 bp plus a
poly(A)+ tail (Fig. 1B) which closely agrees with the major
V1.45 kb transcript detected in Northern blots of rat brain
RNA [6].
3.2. Structural analysis of the Kcnj13 5P £anking region
Approximately 800 bp of the 5P £anking region upstream of
exon 1 in the V-phage clone 6A were sequenced as an initial
step to analyze the Kcnj13 promoter (Fig. 2). A consensus
TATA-box (TATAAA) at position 330 and a CAAT-box
at position 372, which together mediate transcriptional ini-
tiation via TFIID and RNA polymerase II [21^23], were im-
mediately detected in the core promoter in close proximity to
the initiator region. Computer analysis with the MatInspector
program [24] identi¢ed further cis regulatory elements in the
rat gene: four AP1 sites (positions 377, 3474, 3505 and
3797), known to be targets for c-Jun/c-Fos heterodimers
(one of them overlapping with the CAAT-box); an inverted
CAAT-box (position 393); two recognition motifs for helix^
loop^helix AP4 transcription factors (position 358, 3831);
two CAAT-box enhancer binding protein L sites, known to
regulate cellular di¡erentiation [25] ; and an inverted CRE
sequence (position 3207), recognized by stimulus-induced
transcription factors of the CREB family [26]. A BLAST
search [27] of the recently released sequence database of the
Human Genome Project with the rKir7.1 genomic sequence
identi¢ed the 5P £anking region of the hKir7.1 gene (accession
number AC016692) which shows 90% identity with the initial
422 bp of the rKir7.1 5P £anking region including all cis reg-
ulatory elements.
3.3. Promoter activity of the Kcnj13 5P £anking region
In situ hybridizations in rat brain identi¢ed Kir7.1 tran-
scripts only in epithelial cells of the choroid plexus and the
meninges but not in neurons [6]. These results are con¢rmed
Fig. 2. 5P region of the rat Kir7.1 gene. Nucleotide sequences of the
5P £anking region (884 bp) of Kcnj13 and the initial part of cDNA
are shown. Numbers represent nucleotide positions relative to the
transcriptional initiation site (+1). The 5P UTR of the cDNA and
the partial ORF are shaded in gray and black, respectively. Poten-
tial transcription factor binding sites are depicted. Inverted consen-
sus sequences are marked by arrowheads.
Fig. 3. Western blot analysis of Kir7.1 in rat brain and cell lines.
Left panel: 20 Wg total protein from rat hippocampus (hipp), cere-
bellum (cereb), cortex, meninges (menin) and choroid plexus (cp)
were probed with polyclonal rabbit Kir7.1 antibody (1:1500). Right
panel: total cell extracts of N2A, HEK293 and FRTL-5 cells (20
Wg) and rat cp (3.5 Wg) serving as control were analyzed for Kir7.1
expression. No signals were detected in parallel blots of FRTL-5
cells and cp that were probed with Kir7.1 antibodies preincubated
with the antigen (data not shown).
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here on the protein level by Western blots in which equal
amounts of whole cell protein from di¡erent brain tissues
were blotted. Fig. 3 (left panel) shows several-fold higher lev-
els of Kir7.1 protein in choroid plexus compared to the me-
ninges and the absence of Kir7.1 from neuronal cells. To
assess a potential role of promoter elements in the 5P £anking
region of Kcnj13 on this di¡erential distribution, we investi-
gated their ability to drive expression of the luciferase reporter
gene in two representative cell lines: FRTL-5 cells originating
from thyroid gland and N2A neuroblastoma cells. We found
that FRTL-5 cells use the same transcriptional start site at
position 3133 as determined for the rat brain (data not
shown), and Nakamura et al. [9] have recently reported on
the expression of Kir7.1 mRNA in this cell line. Fig. 3 (right
panel) documents that Kir7.1 protein is strongly present in
FRTL-5 but absent from both N2A and HEK293 cells (also
con¢rmed by RT-PCR), and thus demonstrates the suitability
of these cell lines for a comparative promoter analysis. Ini-
tially, 996 bp, consisting of 884 bp 5P £anking region and 112
bp of exon 1, were inserted into the pGL3 basic vector
(termed pLuc884), and extracts from each transfected cell
line were assayed for luciferase activity. pGL3 basic which
represents the low background of the reporter vector, and
pGL3-promoter, in which luciferase expression is driven by
the SV40 promoter, were used as controls. To identify discrete
regions controlling transcriptional activity, several deletion
constructs of pLuc884 as well as a construct with a 2120 bp
5P £anking region identi¢ed from V-phage clone 4B
(pLuc2120) were tested for their reporter gene response
(Fig. 4).
Our data show that, in general, the relative promoter activ-
ity of all Kcnj13 constructs obtained in N2A cells did not
di¡er signi¢cantly from that obtained in FRTL-5 thyroid
gland cells. These ¢ndings indicate that regulatory elements
mediating cell-speci¢c expression are absent at least 2120 bp
upstream of the transcription site. In more detail, with
pLuc884 used as standard, the luciferase activity in constructs
generated by successive deletions of pLuc884 (pLuc357,
pLuc178, pLuc138) was enhanced by 50^70% in both cell
lines. Of all analyzed constructs, pLuc138 showed the highest
transcriptional activity which was comparable to the activity
driven by the viral SV40 promoter in pGL3-promoter. How-
ever, further deletions of another 75 bp (pLuc63) which re-
moved the CAAT-box (373) resulted in a 60^70% decrease of
luciferase activity relative to pLuc884. This dramatic reduc-
tion of luciferase activity indicates that pLuc138 comprises the
minimal promoter of Kcnj13. The essential function of this
region is also demonstrated in pLucv470 that lacks 470 bp
upstream of the transcription initiation site and showed a lu-
ciferase activity comparable to the pGL3-basic control (Fig. 4).
An elongated 5P £anking region beyond bp 884 as in the
reporter plasmid pLuc2120 revealed transcriptional activity
Fig. 4. Analysis of Kir7.1 promoter activity in FRTL-5 and N2A cells. FRTL-5 (black bars) and N2A (gray bars) cells were transfected with
each of the pLuc plasmids containing the ¢re£y luciferase reporter under control of di¡erent fragments of the Kir7.1 promoter. Total luciferase
activity was measured after 48 h. The e⁄ciency of transfection was normalized by co-transfecting the Renilla luciferase vector pRL-TK, and
promoter activity was normalized to the activity of the pLuc884 construct (broken line). Results are presented as mean þ S.D. (n = 3). Position
of the transcriptional initiation site (+1) is indicated by the dotted line.
Fig. 5. In£uence of signaling pathways on the activity of the Kcnj13
promoter. HEK293 cells were individually transfected with various
pLuc luciferase reporter constructs (black bars) or co-transfected
with both constitutively active MEKK (hatched bars) and catalytic
PKA subunits (dotted bars). Luciferase activity was measured and
normalized to pLuc884 as described in the legend to Fig. 4.
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that was reduced by 40% compared to pLuc884, but again
almost identical for both cell lines and, thus, appears to
lack cell-speci¢c regulatory elements. In summary, we con-
clude that, independent of the host cell line, most of the lu-
ciferase activity of the analyzed constructs depends on strong
core promoter elements in Kir7.1 that mediate an e¡ective
binding of RNA polymerase II.
In search for cis regulatory elements that could a¡ect tran-
scriptional e⁄ciency in response to cellular signaling path-
ways, we ¢rst investigated a CRE site (position 3201) origi-
nally identi¢ed as a target for phosphorylated CREB and thus
being involved in cell proliferation, di¡erentiation and adap-
tive processes [26]. Because CRE binding protein transcription
factors bind to CRE after PKA phosphorylation at amino
acid position 133 [28], catalytic subunits of PKA were trans-
fected together with the various luciferase reporter constructs
in HEK293 cells. The results shown in Fig. 5, however, dem-
onstrate that overexpressed PKA subunits only insigni¢cantly
enhanced the luciferase activity of all tested constructs, indi-
cating a negligible role of the CRE site in the Kcnj13 pro-
moter.
In contrast, the AP1 site that overlaps with the CAAT-box
in the core promoter (position 372) was found to negatively
a¡ect the transcriptional activity of the Kir7.1 promoter. AP1
sites bind c-Jun/c-Fos heterodimeric transcription factors fol-
lowing phosphorylation and activation by c-Jun N-terminal
kinase, a MAP kinase isoform [29], which in turn is activated
by MEKK [30]. We therefore investigated the function of the
AP1 site by co-transfecting reporter constructs with an expres-
sion vector encoding constitutively active MEKK (Strata-
gene). Fig. 5 shows that constructs that comprise the
CAAT-box/AP1 region yielded luciferase activity levels that
were generally reduced by V50%, whereas in pLuc63 in
which the CAAT-box/AP1 site was deleted, the activity rather
increased in the presence of MEKK. Thus, as has been sug-
gested for NF-Y and SP1 transcription factors in the mouse
Kir2.1 gene [18], binding of activated c-Jun/c-Fos close to the
transcriptional initiation site of Kcnj13 may negatively inter-
fere with binding of the basal transcriptional apparatus under
our experimental conditions.
In summary, we have shown that in epithelial Kir7.1 sub-
units high transcriptional levels that compare to those driven
by the SV40 promoter are dependent on the presence of
strong core promoter elements, a TATA-box and a CAAT-
box, adjacent to the transcriptional start site. Similarly, these
motifs are present in the 5P £anking region of epithelial Kir1.1
channels [15] but are absent from the promoters of Kir
subunits typically expressed in the central nervous system
(e.g. [16,18,31]). In the genes of K channel subunits analyzed
so far the activity of the minimal promoter is strongly con-
trolled in a tissue-speci¢c manner by cis-acting elements. In
both Kv1.5 and Kir2.1 subunits, repressor/silencer elements
that di¡erentiate between neuronal and non-neuronal cells
have been identi¢ed close to the transcriptional start site
[13,18].
Generally, tissue-selective repressor or enhancer elements in
various genes have been located within intronic or exonic
sequences in the proximal part of the 5P £anking region
(e.g. REST; [32^34]) as well as several ten thousand bases
up- or downstream of the coding region [35,36]. Our reporter
gene analysis indicates that within the ¢rst 2120 bp upstream
of the transcriptional start site in Kcnj13, despite some general
repressor activity, no tissue-speci¢c regulatory elements are
present. In the future bacterial arti¢cial chromosomes
(s 100 kb) containing the Kir7.1 gene might represent a use-
ful extension to our study to search for remote regulatory
elements that confer neuron-speci¢c repression or transcrip-
tional enhancement in epithelia.
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